{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:08:36Z","timestamp":1791173316253,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.canrad.2012.05.007","type":"journal-article","created":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T01:48:51Z","timestamp":1342662531000},"page":"456-461","source":"Crossref","is-referenced-by-count":5,"title":["\u00c9valuation et prise en charge de la toxicit\u00e9 cutan\u00e9e en cours de radioth\u00e9rapie"],"prefix":"10.1016","volume":"16","author":[{"given":"A.","family":"Modesto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-C.","family":"Faivre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Granel-Brocard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-G.","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Pointreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2012.05.007_bib0005","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.ijrobp.2011.09.021","article-title":"Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized Phase III clinical trial","volume":"83","author":"Pinnix","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2012.05.007_bib0010","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/09553009014550911","article-title":"The skin: its structure and response to ionizing radiation","volume":"57","author":"Hopewell","year":"1990","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.canrad.2012.05.007_bib0015","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0167-8140(01)00327-9","article-title":"Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study","volume":"59","author":"Bostrom","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2012.05.007_bib0020","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.canrad.2010.03.015","article-title":"Dose de tol\u00e9rance des tissus sains\u00a0: la peau et les phan\u00e8res","volume":"14","author":"Ginot","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2012.05.007_bib0025","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3109\/02841867509132688","article-title":"Skin reactions after different fractionation schedules giving the same cumulative radiation effect","volume":"14","author":"Turesson","year":"1975","journal-title":"Acta Radiol Ther Phys Biol"},{"key":"10.1016\/j.canrad.2012.05.007_bib0030","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.soncn.2011.02.009","article-title":"Evidence-based skin care management in radiation therapy: clinical update","volume":"27","author":"McQuestion","year":"2011","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/j.canrad.2012.05.007_bib0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.radonc.2011.12.002","article-title":"Common variants of eNOS and XRCC1\u00a0genes may predict acute skin toxicity in breast cancer patients receiving radiotherapy after breast conserving surgery","volume":"103","author":"Terrazzino","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2012.05.007_bib0040","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0167-8140(00)00322-4","article-title":"The impact of skin washing with water and soap during breast irradiation: a randomized study","volume":"58","author":"Roy","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2012.05.007_bib0045","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer","volume":"347","author":"Fisher","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2012.05.007_bib0050","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1200\/JCO.2007.15.9442","article-title":"Should intensity-modulated radiation therapy be the standard of care in the conservatively managed breast cancer patient?","volume":"26","author":"Haffty","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2012.05.007_bib0055","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1200\/JCO.2007.15.2488","article-title":"A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis","volume":"26","author":"Pignol","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2012.05.007_bib0060","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/COC.0b013e31820059a2","article-title":"Three-field electron\/minitangent photon technique offer dosimetric advantages to a multifield, photon-only technique for accelerated partial breast irradiation if well implemented","volume":"34","author":"Bourgier","year":"2011","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.canrad.2012.05.007_bib0065","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.radonc.2006.10.011","article-title":"Multileaf field-in-field forward-planned intensity-modulated dose compensation for whole-breast irradiation is associated with reduced contralateral breast dose: a phantom model comparison","volume":"82","author":"Borghero","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2012.05.007_bib0070","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.meddos.2011.03.002","article-title":"Simplified field-in-field technique for a large-scale implementation in breast radiation treatment","volume":"7","author":"Fournier-Bidoz","year":"2012","journal-title":"Med Dosim"},{"key":"10.1016\/j.canrad.2012.05.007_bib0075","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0360-3016(00)00782-3","article-title":"Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13","volume":"48","author":"Fisher","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2012.05.007_bib0080","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1200\/JCO.2004.07.063","article-title":"Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer","volume":"22","author":"Pommier","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2012.05.007_bib0085","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1200\/JCO.2005.04.9148","article-title":"Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99-13","volume":"24","author":"Elliott","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2012.05.007_bib0090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1471-2407-6-119","article-title":"A new extract of the plant Calendula officinalis produces a dual in vitro effect: cytotoxic anti-tumor activity and lymphocyte activation","volume":"6","author":"Jimenez-Medina","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canrad.2012.05.007_bib0095","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.canrad.2009.04.003","article-title":"Int\u00e9r\u00eat des applications cutan\u00e9es en cours de radioth\u00e9rapie pour la pr\u00e9vention et le traitement des \u00e9pith\u00e9liites radio-induites","volume":"13","author":"Chargari","year":"2009","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2012.05.007_bib0100","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1046\/j.1365-2133.2002.04751.x","article-title":"Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study","volume":"146","author":"Schmuth","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.canrad.2012.05.007_bib0105","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ijrobp.2006.12.049","article-title":"Randomized comparison of dry dressings versus hydrogel in management of radiation-induced moist desquamation","volume":"68","author":"Macmillan","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2012.05.007_bib0110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.radonc.2011.05.014","article-title":"Can we decrease the skin reaction in breast cancer patients using hyaluronic acid during radiation therapy? Results of phase III randomised trial","volume":"100","author":"Kirova","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2012.05.007_bib0115","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0360-3016(96)00320-3","article-title":"Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity","volume":"36","author":"Williams","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2012.05.007_bib0120","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/02841869409098406","article-title":"Skin protection by sucralfate cream during electron beam therapy","volume":"33","author":"Maiche","year":"1994","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2012.05.007_bib0125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.radonc.2004.07.032","article-title":"Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial","volume":"73","author":"Wells","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2012.05.007_bib0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.canrad.2010.02.001","article-title":"Traitement et pr\u00e9vention des radiodermites aigu\u00ebs","volume":"14","author":"Benomar","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2012.05.007_bib0135","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2012.05.007_bib0140","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/annonc\/mdi279","article-title":"Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors","volume":"16","author":"Segaert","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2012.05.007_bib0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3\u00a0randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2012.05.007_bib0150","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMc071075","article-title":"Severe cutaneous reaction during radiation therapy with concurrent cetuximab","volume":"357","author":"Budach","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2012.05.007_bib0155","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/annonc\/mdr139","article-title":"Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelines","volume":"22","author":"Bernier","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2012.05.007_bib0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11523-009-0114-0","article-title":"Skin toxicities associated with epidermal growth factor receptor inhibitors","volume":"4","author":"Li","year":"2009","journal-title":"Target Oncol"},{"key":"10.1016\/j.canrad.2012.05.007_bib0165","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1200\/JCO.2008.17.9549","article-title":"Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831","volume":"27","author":"Halyard","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2012.05.007_bib0170","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/annonc\/mdn029","article-title":"Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric study","volume":"19","author":"Belkacemi","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2012.05.007_bib0175","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejca.2010.08.013","article-title":"The acute skin and heart toxicity of a concurrent association of trastuzumab and locoregional breast radiotherapy including internal mammary chain: a single-institution study","volume":"47","author":"Caussa","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2012.05.007_bib0180","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1200\/JCO.2007.13.6929","article-title":"Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014","volume":"26","author":"Persky","year":"2008","journal-title":"J Clin Oncol"}],"updated-by":[{"DOI":"10.1016\/j.canrad.2012.10.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000}}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832181200128X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832181200128X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T21:54:02Z","timestamp":1542837242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S127832181200128X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":36,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S127832181200128X"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2012.05.007","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}